Skip to search formSkip to main contentSkip to account menu

KDAN 18

Known as: KDAN-18 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AmidesNaltrexone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands
IntroductionDuring the past decade, substantial evidence has documented that opioid receptor heterodimers form in cell lines… 
Highly Cited
2004
Highly Cited
2004
A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes.
To characterize delta- and kappa-opioid receptor phenotypes, bivalent ligands (KDAN series) containing delta-antagonist… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)